UCB SA (UCBJF)
304.84
-0.75
(-0.25%)
USD |
OTCM |
Oct 27, 16:00
UCB Price : 304.84 for Oct. 27, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 27, 2026 | 292.20 | 304.84 | 292.20 | 304.84 | 65.00 |
| Oct 26, 2026 | 305.59 | 305.59 | 305.59 | 305.59 | 31.00 |
| Oct 23, 2026 | 306.84 | 306.84 | 289.01 | 293.39 | 349.00 |
| Oct 22, 2026 | 285.75 | 297.34 | 285.75 | 297.34 | 7507.00 |
| Oct 21, 2026 | 250.34 | 250.34 | 250.34 | 250.34 | 52.00 |
| Oct 20, 2026 | 237.84 | 237.84 | 237.84 | 237.84 | 104.00 |
| Oct 19, 2026 | 237.84 | 237.84 | 237.84 | 237.84 | 15.00 |
| Oct 16, 2026 | 239.14 | 239.14 | 239.14 | 239.14 | 107.00 |
| Oct 15, 2026 | 240.24 | 240.24 | 240.24 | 240.24 | 10.00 |
| Oct 14, 2026 | 235.94 | 235.94 | 235.94 | 235.94 | 180.00 |
| Oct 13, 2026 | 235.94 | 235.94 | 235.94 | 235.94 | 61.00 |
| Oct 12, 2026 | 238.40 | 238.40 | 238.40 | 238.40 | 13.00 |
| Oct 09, 2026 | 236.94 | 236.94 | 232.62 | 232.62 | 183.00 |
| Oct 08, 2026 | 219.60 | 236.66 | 219.60 | 236.66 | 11.00 |
| Oct 07, 2026 | 236.94 | 236.94 | 236.94 | 236.94 | 25.00 |
| Oct 06, 2026 | 236.94 | 236.94 | 230.50 | 236.94 | 86.00 |
| Oct 05, 2026 | 235.44 | 235.44 | 235.44 | 235.44 | 41.00 |
| Oct 02, 2026 | 238.54 | 238.54 | 238.54 | 238.54 | 17.00 |
| Oct 01, 2026 | 236.90 | 236.90 | 233.44 | 233.44 | 129.00 |
| Sep 30, 2026 | 246.64 | 246.64 | 246.64 | 246.64 | 0.000 |
| Sep 29, 2026 | 247.55 | 247.55 | 246.64 | 246.64 | 74.00 |
| Sep 28, 2026 | 250.59 | 250.59 | 241.48 | 246.11 | 288.00 |
| Sep 25, 2026 | 254.09 | 254.09 | 235.66 | 235.66 | 34.00 |
| Sep 24, 2026 | 230.16 | 248.34 | 230.16 | 243.88 | 543.00 |
| Sep 23, 2026 | 236.49 | 236.49 | 236.49 | 236.49 | 50.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 271.01 |
| Eli Lilly & Co. | 1289.43 |
| Novo Nordisk A/S | 38.28 |
| Pfizer Inc. | 29.48 |
| Teva Pharmaceutical Industries Ltd. | 39.97 |
Price Related Metrics
| PE Ratio | 23.12 |
| PS Ratio | 5.950 |
| PEG Ratio | 0.0258 |
| Price to Free Cash Flow | 42.03 |
| Earnings Yield | 4.33% |
| Market Cap | 58.12B |
| PEGY Ratio | 0.0258 |
| Operating PE Ratio | 18.69 |
| Normalized PE Ratio | 22.92 |